High USP4 is associated with a worse outcome in gastric cancer (Tao and You 2022) and pancreatic cancer (Wang et al. 2020) and a better outcome in esophageal cancer (Yao et al. 2017). Here, USP4 is linked to familial pancreatic carcinoma.